- Home
- ACTU vs DRTS Comparison
ACTU vs DRTS Comparison
Compare ACTU & DRTS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ACTU
- DRTS
- Stock Information
- Founded
- ACTU 2015
- DRTS 2015
- Country
- ACTU United States
- DRTS Israel
- Employees
- ACTU N/A
- DRTS N/A
- Industry
- ACTU
- DRTS Medical/Dental Instruments
- Sector
- ACTU
- DRTS Health Care
- Exchange
- ACTU NYSE
- DRTS Nasdaq
- Market Cap
- ACTU 153.1M
- DRTS 159.1M
- IPO Year
- ACTU 2024
- DRTS N/A
- Fundamental
- Price
- ACTU $8.98
- DRTS $2.32
- Analyst Decision
- ACTU
- DRTS Strong Buy
- Analyst Count
- ACTU 0
- DRTS 3
- Target Price
- ACTU N/A
- DRTS $8.00
- AVG Volume (30 Days)
- ACTU 59.7K
- DRTS 25.4K
- Earning Date
- ACTU 11-13-2024
- DRTS 11-19-2024
- Dividend Yield
- ACTU N/A
- DRTS N/A
- EPS Growth
- ACTU N/A
- DRTS N/A
- EPS
- ACTU N/A
- DRTS N/A
- Revenue
- ACTU N/A
- DRTS N/A
- Revenue This Year
- ACTU N/A
- DRTS N/A
- Revenue Next Year
- ACTU N/A
- DRTS N/A
- P/E Ratio
- ACTU N/A
- DRTS N/A
- Revenue Growth
- ACTU N/A
- DRTS N/A
- 52 Week Low
- ACTU $5.51
- DRTS $1.75
- 52 Week High
- ACTU $10.16
- DRTS $3.40
- Technical
- Relative Strength Index (RSI)
- ACTU N/A
- DRTS 55.81
- Support Level
- ACTU N/A
- DRTS $2.20
- Resistance Level
- ACTU N/A
- DRTS $2.30
- Average True Range (ATR)
- ACTU 0.00
- DRTS 0.07
- MACD
- ACTU 0.00
- DRTS 0.01
- Stochastic Oscillator
- ACTU 0.00
- DRTS 100.00
About ACTU ACTUATE THERAPEUTICS INC
Actuate Therapeutics Inc is a clinical stage biopharmaceutical company focused on developing therapies for the treatment of high impact, difficult to treat cancers through the inhibition of glycogen synthase kinase-3 (GSK-3). It is developing elraglusib (formerly 9-ING-41), a small molecule that is designed to enter cancer cells and block the function of the enzyme GSK-3β, a master regulator of complex biological signaling cascades, including those mediated by oncogenes, that lead to tumor cell survival, growth, migration, and invasion.
About DRTS Alpha Tau Medical Ltd.
Alpha Tau Medical Ltd is a clinical-stage oncology therapeutics company focused on harnessing the innate relative biological effectiveness and short range of alpha particles for use as localized radiation therapy for solid tumors. The Alpha CaRT technology of the company utilizes the therapeutic properties of alpha particles aiming to overcome, and harness for benefit for alpha radiation's range. The company derives maximum revenue from Israel.